Our advice for clinicians on the coronavirus is here.
If you are a member of the public looking for information and advice about coronavirus (COVID-19), including information about the COVID-19 vaccine, go to the NHS website. You can also find guidance and support on the GOV.UK website.
About cancer
Find out what we are doing to improve cancer services in England.
Prevention and public health
We will significantly reduce the 40% of cancers caused by behavioural, lifestyle and environmental factors.
Diagnosing cancer earlier and faster
Earlier diagnosis makes it more likely that patients will receive treatments that can cure cancer. It saves lives.
Cancer Experience of Care
We are improving patient experience and putting it on an equal footing with other clinical outcomes.
Personalised care and improving quality of life outcomes
We will support people affected by cancer to live healthy and happy lives.
Cancer Alliances, improving care locally
People affected by cancer and clinical leaders will be in the driving seat for improving quality.
You may also be interested in
The NHS Long Term Plan and commitments for cancer
Cally Palmer, NHS England’s National Cancer Director shares her thoughts on the NHS Long Term Plan and what it means for cancer.
Cally gives an overview of cancer screening programmes, the new 28-day faster diagnosis standard and the care and treatment options available. Cally also talks about the Targeted Lung Health Checks programme, one of the first programmes to roll out of the Long Term Plan.
Investing in radiotherapy to fight cancer
Watch this short video which shows how we are investing in radiotherapy to fight cancer.
Funded by NHS England, University College London Hospitals are one of the first hospitals to receive a new LINAC radiotherapy machine.
In this video, patient Chris Duggan talks about the treatment he is experiencing, and Dr. Yen-Ching Chang describes how this new equipment works.
News and blogs
Hundreds of patients to get life-extending lung cancer drug on the NHS
Hundreds of people with a form of the most common form of lung cancer could survive twice as long with the disease, thanks to a drug now available on the NHS. The drug, durvalumab, can double the overall time someone can survive with an aggressive form of lung cancer from two and a half to […]